To minimize potential damage to normal cells, we chose the functional molecule ABHD11‐AS1, which was differentially expressed in ICC and adjacent tissues and responded to mechanical signals from the ECM, as the intracellular regulatory target. The gene discussed is ABHD11; the disease is intrahepatic cholangiocarcinoma.